N,N'-bis(2-ethyl-1,3-dioxolane)kryptocyanine: potential photochemotherapy agent; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6439085 |
| MeSH ID | M0145694 |
| Synonym |
|---|
| edkc |
| n,n'-bis(2-ethyl-1,3-dioxolane)kryptocyanine |
| quinolinium, 1-(2-(1,3-dioxolan-2-yl)ethyl)-4-(3-(1-(2-(1,3-dioxolan-2-yl)ethyl)-4(1h)-quinolinylidene)-1-propenyl)-, bromide |
| Excerpt | Reference | Relevance |
|---|---|---|
| " The mechanism may involve electron transfer to oxygen and subsequent formation of toxic photoproducts from EDKC+." | ( Phototoxicity mechanism of a kryptocyanine dye in human red cell membranes and isolated murine mitochondria. Ara, G; Kochevar, IE; Valdes-Aguilera, O, 1988) | 0.27 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.51) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||